英威騰(002334.SZ):設中山英威騰精密技術 提升產品交付質量
格隆匯12月2日丨英威騰(002334.SZ)公佈,為了強化供應鏈保障體系,進一步增強集團整體解決方案能力,公司擬使用自有資金設立全資子公司中山市英威騰精密技術有限公司,註冊資本為人民幣2000萬元。近日,經中山市市場監督管理局核准,中山市英威騰精密技術有限公司完成了工商註冊登記手續並取得了營業執照。
此次設立全資子公司是為了提升公司產品交付質量,達到降本增效的目的。此次投資對公司整體業務佈局具有重大的戰略意義,有利於完善供應鏈系統,解決產品交付痛點,促進整體解決方案能力的提升,提升集團綜合競爭力和盈利水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.